Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ARCT
ARCT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARCT News
Arcturus Therapeutics Q1 2026 Earnings Call Insights
2d ago
seekingalpha
Arcturus Therapeutics Q1 Earnings Analysis
3d ago
seekingalpha
Arcturus Therapeutics Set to Announce Q1 Earnings on May 7
4d ago
seekingalpha
Transformation of Value in Biotechnology Sector
Apr 20 2026
Globenewswire
Biotechnology Sector Undergoes Value Transformation
Apr 20 2026
Newsfilter
Cathie Wood Increases Holdings in Three Stocks Amid Market Volatility
Mar 25 2026
Fool
Cathie Wood Quietly Adds to Three Stocks Amid Market Decline
Mar 23 2026
Fool
Cathie Wood Increases Stakes in Figma, Arcturus, and 10x Genomics
Mar 23 2026
NASDAQ.COM
Arcturus Therapeutics Q4 2025 Earnings Call Insights
Mar 04 2026
seekingalpha
Arcturus Therapeutics Reports Disappointing Earnings
Mar 03 2026
seekingalpha
Arcturus Therapeutics Set to Announce Q4 Earnings on March 3rd
Mar 02 2026
seekingalpha
Arcturus to Present mRNA Technologies at J.P. Morgan Healthcare Conference
Jan 08 2026
Businesswire
Arcturus Announces Launch of 12-Week Cystic Fibrosis Study in 2026, Facing Cost Management and KOSTAIVE BLA Delays
Nov 10 2025
SeekingAlpha
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm
Nov 10 2025
PRnewswire
Cathie Wood Reduces Holdings in AMD and Other U.S. Tech Stocks, Increases Investment in Baidu and Biotech Sectors
Oct 25 2025
TipRanks
Molina Healthcare Analyst Adopts Bearish Stance; Check Out the Top 5 Downgrades for Friday
Oct 24 2025
Benzinga
Show More News
